Abstract Objective Coronavirus disease 2019 (COVID‐19) outbreak is a major challenge all
over the world, without acknowledged treatment. Intravenous immunoglobulin (IVIG) has …

Background The effective treatment of coronavirus disease 2019 (COVID-19) remains
unclear. We reported successful use of high-dose intravenous immunoglobulin (IVIg) in …

The outbreak of coronavirus disease 2019 (COVID-19) has spread rapidly in China. Until
now, no definite effective treatment has been identified. We reported on 3 patients with …

Background Currently, there is no specific drug for the treatment of coronavirus disease
2019 (COVID-19). Therapeutic benefits of intravenous immunoglobulin (IVIG) have been …

Abstract Background Coronavirus disease 2019 (COVID-19) has infected people in many
countries worldwide. Discovering an effective treatment for this disease, particularly in …

Background The newly discovered coronavirus has turned into coronavirus disease 2019
(COVID-19) pandemic and it rages at an unprecedented rate. Considering the findings of …

Background The benefit of IVIG (Intravenous Immunoglobulin) therapy for COVID-19
remains controversial. We performed a meta-analysis to investigate the efficacy of IVIG …

Abstract Treatment with immunomodulators, such as intravenous immunoglobulin (IVIG),
may attenuate inflammatory responses observed in the severe stages of acute respiratory …

Introduction During the recent months, COVID-19 has turned to a global crisis claiming high
mortality and morbidity among populations. Despite the high prevalence of the disease, it …

Abstract Background Hyperimmune anti-COVID-19 Intravenous Immunoglobulin (C-IVIG) is
an unexplored therapy amidst the rapidly evolving spectrum of medical therapies for COVID …